Research
Area 3
Liver, digestive system and metabolism
Area leader:
Dr. Julián Panés
(Hospital Clínic)
Area 3 has 14 teams and is formed by researchers who combine their skills in clinical, experimental and basic research. Its translational research approach has succeeded in contributing important breakthroughs in terms of knowledge, diagnostic techniques and the treatment of pathologies of interest to the groups.
The mission of the different teams composing this area is to apply innovative methods to different medical problems: cirrhosis and liver complications, inflammatory and neoplastic diseases of the digestive tract, metabolic disorders in diabetes, metabolic bone diseases and foetal medicine. The Liver, Digestive System and Metabolism area is one of the most productive areas, with many publications in the first quartile of the Science Citation Index. It has also proved to be one of the most competitive areas in terms of private investment and competitive public grants.
- Gynecological endocrinology and human reproduction
- Fetal and perinatal medicine
- Metabolic regulation and molecular pathology
- Viral hepatitis in the immune competent host and in liver transplant patients.
- Physiopathology and treatment of ascites and altered renal function in liver cirrhosis.
- Hepatic oncology
- Liver hemodynamics and portal hypertension. Digestive bleeding secondary to ruptured esophageal varicose veins.
- Inflammatory bowel disease (IBD)
- Cholestasis and bone pathology.
- Mitochondrial regulation of cell death and steatohepatitis.
- Liver transplantation and graft viability
- Gastrointestinal and pancreatic oncology
- Hereditary metabolic diseases
- Genomic Programming of Beta Cells and Diabetes
- Diabetes: metabolic and molecular networks.